MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0083994
Alenvision Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.01 Cr
▲ 11% YoY
Net loss · FY 2025
₹83.74 Lakh
Net margin -7.6%
EBITDA · FY 2025
-₹58.89 Lakh
EBITDA margin -5.3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹50 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
89
Provident fund records
Directors on board
2
As per MCA filings
About Alenvision Pharma Private Limited
Data last updated:
Alenvision Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2020PTC340540. Its GSTIN is 06AATCA5467D1ZG (Haryana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹50 Lakh. It is led by directors Mandeep Singh and Rajesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.01 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net loss of ₹83.74 Lakh (net margin -7.6%) and EBITDA of -₹58.89 Lakh (EBITDA margin -5.3%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years.
The company has about 89 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Alenvision Pharma. Court records list 18 cases involving the company, including 17 filed by the company and 1 filed against it; 10 cases are pending.
Alenvision Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0083994). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website alenvision.com.
Company details
CIN U24100MH2020PTC340540
Registration Number 340540
Incorporation Date 11 June 2020
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0083994
Key People
Mandeep Singh Director Rajesh Kumar Director Recognitions & Rankings of Alenvision Pharma
Contact details
Alenvision Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is alenvision.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address216 Hi Tech Shopping Centre, Near V.B. Nagar Police Station Kurla West, Mumbai, Maharashtra, India – 400070
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Alenvision Pharma Private Limited, buy the company report.
Comprehensive company report
Alenvision Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Alenvision Pharma operates one associated brand: Alenvision Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and supplying pharmaceutical products with a focus on quality and innovation in India. | alenvision.com |
Business activity
The main business activity of Alenvision Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Alenvision Pharma Private Limited, buy the company report.
Financials of Alenvision Pharma Private Limited
FY 2025 filings availableAlenvision Pharma Private Limited reported revenue of ₹11.01 Cr (up 11% YoY) for FY 2025.
Revenue · FY 2025
₹11.01 Cr ▲ 11%
Net loss · FY 2025
₹83.74 Lakh margin -7.6%
EBITDA · FY 2025
-₹58.89 Lakh margin -5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 11%
3 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▲ 84%
3 years · compounded
▼ 53%
Revenue rose 11% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 9%. EBITDA rose 84% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹58.89 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹83.74 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -5.3% | ||||
| Net Profit Margin | -7.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Alenvision Pharma Private Limited, buy the company report.
Board of directors of Alenvision Pharma Private Limited
Alenvision Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mandeep Singh Also directs: Indmark Biotech Private Limited, Alenrise Retail Private Limited | Director | 29 Mar 2024 | 2 Years 7 Months | Current |
| Rajesh Kumar | Director | 14 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
Alenvision Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RN Chemicals & Pharmaceutical Private Limited | ₹11.08 Cr (FY 2025) | 970.0% | Solan, Himachal Pradesh, India | |||
| Texas Pharmaceuticals Private Limited | ₹11.03 Cr (FY 2025) | 3.0% | Karnal, Haryana, India | |||
| Alenvision Pharma Private Limitedthis company | ₹11.01 Cr (FY 2025) | -₹83.74 Lakh | -7.6% | 11.0% | 89 | Mumbai, Maharashtra, India |
| Nilrise Pharmaceuticals Private Limited | ₹10.92 Cr (FY 2025) | 6.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Alenvision Pharma Private Limited, buy the company report.
Auditor
Alenvision Pharma Private Limited is audited by GOYAL JYOTI & COMPANY for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GOYAL JYOTI & COMPANY | FY 2023 | 539129 |
Shareholding
The shareholding of Alenvision Pharma Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Alenvision Pharma Private Limited, buy the company report.
Legal cases
Alenvision Pharma Private Limited has 18 court cases on record: 17 filed by Alenvision Pharma, 1 filed against it. 10 cases are pending and 8 are disposed.
Total cases
18
Filed by the company
17
Filed against the company
1
Pending
10
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 17 | 0 | 9 |
| High courts | 1 | 1 | 1 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharmaceutical Medicare Ltd | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Hira Life Medicine Mall and 1 other | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Shree Bhakti Pharma and 1 other | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Shiv Pharma and 1 other | Pending |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S M M Pharma and 1 other | Pending |
To see the full case history of Alenvision Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alenvision Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Alenvision Pharma Private Limited has a workforce of 89 employees on its EPFO records as of Apr 09, 2024, across 1 active EPFO establishment.
Employee count
89
Active EPFO establishments
1
Employee growth
-21.24%
GST
Alenvision Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AATCA5467D1ZG | Haryana | Active | 20 Jul 2020 |
To see the full GST registrations and return filing status of Alenvision Pharma Private Limited, buy the company report.
Recent activity
Alenvision Pharma Private Limited has 5 board changes on record since 2024: 2 appointments and 3 cessations. The latest: Kuldeep Sandhu ceased to be Director on 14 Aug 2025.
AGM
Alenvision Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Kuldeep Sandhu ceased to be Director.
Appointed
Rajesh Kumar was appointed as Director.
Filing
Alenvision Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Abhiraj Sandhu ceased to be Director.
Ceased
Jitender Singh ceased to be Director.
Appointed
Mandeep Singh was appointed as Director.
Incorporation
11 Jun 2020
Alenvision Pharma Private Limited was registered on 11 Jun 2020 with Roc Mumbai & aged 6 years 4 months as per MCA records.
Frequently asked questions
Alenvision Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 June 2020 (6+ years old) and is registered under CIN U24100MH2020PTC340540.
Alenvision Pharma has 2 current directors:
- Mandeep Singh - Director
- Rajesh Kumar - Director
The latest financial statements of Alenvision Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Alenvision Pharma is 06AATCA5467D1ZG, registered in Haryana.
The CIN (Corporate Identification Number) of Alenvision Pharma is U24100MH2020PTC340540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alenvision Pharma has 18 court cases on record: 17 filed by the company and 1 filed against it. 10 are pending. Most are in the district courts.
Alenvision Pharma was incorporated on 11 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Alenvision Pharma by revenue are RN Chemicals & Pharmaceutical Private Limited, Texas Pharmaceuticals Private Limited, Nilrise Pharmaceuticals Private Limited, all in the Healthcare industry (Ayurvedic Products and Services, Formulations), with the same principal business activity (wholesale trading).
Kuldeep Sandhu ceased to be Director on 14 Aug 2025. Rajesh Kumar was appointed as Director on 14 Aug 2025. Abhiraj Sandhu ceased to be Director on 30 Mar 2024. Alenvision Pharma has 5 board changes on record in total.
Yes, Alenvision Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0083994).
Alenvision Pharma can be reached through the website alenvision.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages